-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – CPI-200
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry CPI-200 Drug Details CPI-200 is under development for the treatment of solid tumor. It...
-
Sector Analysis
Saudi Arabia Projects, H1 2022 – Outlook of Major Projects in Saudi Arabia – MEED Insights
Private Sector participation (PSP) Law and Public-private partnership (PPP) Saudi Arabia’s privatisation drive is poised to advance further in 2022, driven by legislative support from Riyadh and its appetite to work more closely with the private sector. The kingdom’s push for PPPs in recent years forms part of its wider strategy to modernise state-owned assets and attract international investors in order to de-risk government spending. Riyadh expects its long-term growth ambitions will attract investors towards its PPP schemes, and has...
-
Sector Analysis
Public Private Partnership (PPP) in the Middle East and North Africa 2021 and beyond – MEED Insights
Modern infrastructure and world-class public services are central to the national visions being pursued across the Middle East and North Africa (Mena), as governments try to meet the needs of growing populations. Equally important, is the goal to grow private sector participation in driving growth and creating jobs. Executed properly, public private partnerships (PPP) will deliver these goals. PPPs provide a model that allows governments to continue developing strategic projects and services without the need to increase direct state capital...